期刊文献+

乳腺癌新辅助化疗的影像学评估研究进展

Research progress on imaging evaluation of neoadjuvant chemotherapy for breast cancer
在线阅读 下载PDF
导出
摘要 随着诊疗技术的不断发展,乳腺癌治疗正逐步进入多种模式相结合的综合治疗时代。新辅助化疗(NAC)具有降低乳腺癌分期、提高保乳率、个体化治疗等优势,在乳腺癌治疗的应用中日益广泛。超声或乳腺钼靶评估NAC疗效均有一定的效果,但在灵敏度、准确度方面存在一定不足,而多模态磁共振成像技术能进一步提高评估NAC疗效的灵敏度和准确度。 With the continuous development of diagnosis and treatment technology,breast cancer treatment is gradually entering the era of comprehensive treatment combining multiple modes.Neoadjuvant chemotherapy(NAC)has the advantages of reducing the stage of breast cancer,improving the breast conserving rate,and individualized treatment,and is increasingly widely used in the treatment of breast cancer.Ultrasound or mammography have shown some effectiveness in evaluating the efficacy of NAC,but there are certain shortcomings in sensitivity and accuracy.Multimodal magnetic resonance imaging technology can further improve the sensitivity and accuracy of evaluating the efficacy of NAC.
作者 文灿平(综述) 王俊(审校) WEN Canping;WANG Jun(The First Clinical Medical College of Gannan Medical University,Ganzhou,Jiangxi 341000,China;Department of Ultrasound Medicine,the First Affiliated Hospital of Gannan Medical University,Ganzhou,Jiangxi 341000,China)
出处 《现代医药卫生》 2024年第21期3748-3754,共7页 Journal of Modern Medicine & Health
关键词 乳腺癌 新辅助化疗 磁共振成像 超声 综述 Breast cancer Neoadjuvant chemotherapy Magnetic resonance imaging Ultrasound Review
作者简介 通信作者:王俊,E-mail:wangguoshou911@126.com。
  • 相关文献

参考文献14

二级参考文献70

  • 1Sina Meisamy. Patrick J B. Eva HB. ct al. Neoadjuvant Chemotherapy of Locally Advanced Breas: Cancer:Predicting Response with in Vivo H MR Spectroscopy A Pilot Study at ,4T[J]. Radiology, 2001,233(2) :424-431.
  • 2Pickles MD, I.owry M. Man, ton D J. et al. Role of Dynamic Contrast Enhanced MRI in ,Monitoring Early Response of Locally Adva,,ced Breasl Cancer to Neoadjuvant Chemotherapy [J]. Breasl Cancer Rcs.200S.91(1) : 1-10.
  • 3Griffiths JR, Glickson JD. Monitoring Pharmacokinetics of Anticancer Drugs, Non invasive Investigation Using Magnetic Reso nance Spectroscnpy[J]. Adv Drug Deliv Rev,2000,,11(1) :75-89.
  • 4Charfare H, l.imongelli S, Purushotham AD, et al. Neoadjuvant Chemotherapy in Breast Cancer[J]. Br J Surg, 2005,92(1):14-23.
  • 5Savannah CP,Jessica EG. Ying Lu, et al. MRI Measurements of Breast Tumor Volume Predict Response to Neoadjuvant Chemo therapy and Recurrence-free Survival[J]. AJR, 2005, 184 (6): 1774-1781.
  • 6Malur S,Wurdingcr SoMoritz A,et al. Comparison of Written Re ports of Mammography for Preoperative Evaluation of Breast Le sions, with Special Emphasis on Magnetic Resonance Mammogra phy[J]. Breast Cancer Res,2001,3(1):55 60.
  • 7Hyhon N. MR Imaging for Assessment of Breast Cancer Response to Neoadjuvant Chemotherapy[J]. Magn Reson Imaging Clin N Am, 2006,14(3) :383-389.
  • 8Lee KC, Moffat BA.Scholt AF. et al. Prospective Early Response Imaging Biomarker for Neoadjuvant Breast Cancer C'hemotherapy[J].Clin Cancer Res,2007,15,13(2 Pt 1) :,143-450.
  • 9Pickles MD,Gibbs P, Lowry M, et al. Diffusion Changes Precede Size Reduction in Neoadjuvant Treatment of Breast Cancer[J]. Magn Reson Imaging,2006,24(7):843-847.
  • 10Manton DJ ,Chaturvedi A, Hubbard A. ct al. Neoadjuvant Chemotherapy in Breast Cancer: Early Response Prediction with Quantitative MR Imaging and Spectroscopy[J]. British J Cancer, 2006, 94(3) :427-135.

共引文献213

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部